The global eClinical solutions market size was estimated at USD 10.28 billion in 2024 and is projected to reach USD 22.74 billion by 2030, growing at a CAGR of 14.39% from 2025 to 2030. Market growth is primarily driven by increasing research and development activities among biopharma and pharmaceutical companies. Additionally, the growing integration of software solutions in clinical trials is anticipated to further accelerate market expansion.
The rising trend of outsourcing and externalizing clinical trials by major pharmaceutical and biotechnological firms is expected to propel the industry at a remarkable pace throughout the forecast period. A stringent regulatory framework for clinical trials and an increasing emphasis on safety monitoring are significantly influencing market growth in developed economies such as the U.S. For example, the U.S. Department of Health and Human Services and the National Institutes of Health have intensified requirements for clinical trial registration and are promoting data transparency and sharing.
Moreover, the rising demand for software solutions to support clinical trials, coupled with growing government grants and an expanding end-user base, is expected to sustain market growth over the coming years.
### Key Market Trends & Insights
– **North America** dominated the global market, accounting for the largest revenue share of 48.88% in 2024. The U.S. held the largest share within North America in 2024.
– **By Product:** The CTMS (Clinical Trial Management System) segment led the market with a 20.27% revenue share in 2024.
– **By Delivery Mode:** The web and cloud-based segment dominated in 2024.
– **By End Use:** The CROs (Contract Research Organizations) segment accounted for the largest revenue share in 2024.
– **By Development Phase:** The Phase III segment dominated with the highest revenue share in 2024.
Download a free sample PDF of the eClinical Solutions Market Intelligence Study by Grand View Research.
### Market Size & Forecast
– **2024 Market Size:** USD 10.28 Billion
– **2030 Projected Market Size:** USD 22.74 Billion
– **CAGR (2025-2030):** 14.39%
– **Largest Regional Market (2024):** North America
### Competitive Landscape
Leading players in the eClinical solutions market are actively pursuing strategies such as expansions, collaborations, and partnerships to enhance their global presence and strengthen their product portfolios.
**Key Players Include:**
– Datatrak International, Inc.
– Oracle
– Parexel International Corporation
– Dassault Systèmes
– Bioclinica
– CRF Health
– ERT Clinical
– eClinicalWorks
– Merative (formerly IBM Watson Health; acquired by Francisco Partners in June 2022)
– Anju Life Sciences Software
– eClinical Solutions
### Recent Developments
– **November 2024:** RealTime eClinical Solutions expanded its Professional Services to support clinical research sites, academic centers, sponsors, and CROs with its comprehensive eClinical suite.
– **June 2023:** ICON plc launched an enhanced Digital Platform for seamless integration of site, sponsor, and patient services with harmonized data delivery, including tools like eCOA, eConsent, and telehealth visits.
– **May 2023:** eClinical Solutions LLC expanded its ML and AI capabilities within the elluminate IQ platform, enabling faster and more scalable data reviews.
– **June 2022:** Medidata Solutions, Inc. (Dassault Systèmes) extended its collaboration with Novotech, a CRO, to expand clinical trials across multiple therapeutic areas.
Explore Horizon Databook, the world’s most comprehensive market intelligence platform by Grand View Research.
### Conclusion
The global eClinical solutions market is poised for strong growth, fueled by increasing digital transformation in clinical research, enhanced data transparency requirements, and a surge in outsourced trials. With expanding AI integration, cloud adoption, and strategic collaborations, the market is expected to evolve rapidly, enabling greater efficiency, compliance, and innovation in clinical trial management.
https://express-press-release.net/news/2025/11/12/1719691
